Alan Auerbach, President & CEO, Director, Ten Percent Owner at Puma Biotechnology, holds 7.10M shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in Radius Health (Ticker: ~RDUS).

See the Hottest Stocks Based on Insider Trading >

Alan Auerbach
Puma Biotechnology (PBYI)
President & CEO, Director, Ten Percent Owner

Ranked #2,079 out of 98,624 Corporate Insiders

Profitable Transactions

28 out of 45 Profitable Transactions

Average Return

+18.20%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

PBYI

A breakdown of Alan Auerbach's holdings

See the Top Stocks by Insiders

Insider Roles

Puma Biotechnology
(PBYI)

President & CEO, Director, Ten Percent Owner

Roles that Alan Auerbach holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Puma Biotechnology
(PBYI)

Rating:Informative Sell

Date:Apr 03, 2019 - Apr 03, 2020

Return:+80.10%

The most profitable trade made by Alan Auerbach

See the Latest Stocks Traded by Insiders

Alan Auerbach's Trading History

PBYI

Puma Biotechnology

Mar 19, 2024

President & CEO, Director, Ten Percent Owner

Uninformative Buy

―

$35.66M

~RDUS

Radius Health

―

List of latest transactions for each holding click on a transaction to see Alan Auerbach's performance on stock

See All Insider Trading from Today

Alan Auerbach insider profile FAQ

What is the percentage of profitable transactions made by Alan Auerbach?

The percentage of profitable transactions made by Alan Auerbach is 62%.

What is the average return per transaction made by Alan Auerbach?

The average return per transaction made by Alan Auerbach is 18.20%.

What stocks does Alan Auerbach hold?

Alan Auerbach holds: PBYI, ~RDUS stocks.

What was Alan Auerbach’s latest transaction?

Alan Auerbach latest transaction was an Uninformative Buy of ―.

What was Alan Auerbach's most profitable transaction?

Alan Auerbach’s most profitable transaction was an Informative Sell of PBYI stock on April 3, 2019. The return on the trade was 80.10%.

What is Alan Auerbach's role in Puma Biotechnology?

Alan Auerbach's role in Puma Biotechnology is President & CEO, Director, Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Alan Auerbach Insider Profile

Alan Auerbach Puma Biotechnology (PBYI)President & CEO, Director, Ten Percent Owner